- $334.51m
- $1.43bn
- $2.75bn
- 55
- 70
- 20
- 46
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,510 | 1,369 | 1,997 | 2,504 | 2,751 |
Cost of Revenue | |||||
Gross Profit | 119 | 290 | 426 | 486 | 460 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,485 | 1,247 | 1,908 | 2,447 | 2,891 |
Operating Profit | 24.7 | 122 | 89.4 | 57.1 | -140 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.53 | 104 | 40.3 | -4.88 | -209 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.95 | 82.4 | 31.7 | -1.84 | -205 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.966 | 88.8 | -6.58 | -31.8 | -204 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.44 | 32.5 | -6.58 | -31.8 | -204 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.508 | 2.37 | -0.773 | -2.6 | -6.26 |